Not all individuals with CLL need therapy. Despite all latest improvements, the iwCLL nevertheless suggests watchful observation for people with asymptomatic ailment.86 This suggestion is based on at the very least two randomized trials comparing observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103,104 The two trials concluded https://richardt145ppq9.blogdanica.com/profile